This topic contains a solution. Click here to go to the answer

Author Question: The board is responsible for ___. a. drawing up the bylaws for the centers operation b. making ... (Read 1994 times)

stevenposner

  • Hero Member
  • *****
  • Posts: 608
The board is responsible for ___.
 
  a. drawing up the bylaws for the centers operation
  b. making policy decisions including goals for the program based on the centers philosophy
  c. making provisions for the centers operations
  d. all of the above

Question 2

The main purpose of the personnel committee is to
 
  a. write the bylaws
  b. advise the chairman of any changes that need to be made
  c. prepare the budget
  d. hire and, if need be fire a director



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tsternbergh47

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

ANSWER:
d

Answer to Question 2

ANSWER:
d




stevenposner

  • Member
  • Posts: 608
Reply 2 on: Sep 15, 2018
Great answer, keep it coming :)


zacnyjessica

  • Member
  • Posts: 345
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

There are over 65,000 known species of protozoa. About 10,000 species are parasitic.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library